These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 6138467

  • 21. The effects of antihypertensive agents on serum lipids and lipoproteins.
    Lardinois CK, Neuman SL.
    Arch Intern Med; 1988 Jun; 148(6):1280-8. PubMed ID: 2897834
    [Abstract] [Full Text] [Related]

  • 22. The effects of adrenergic blockade on lipoproteins using the rat as an experimental model.
    Balasubramaniam S, Simons LA, Hickie JB, Chang S.
    Artery; 1990 Jun; 17(2):60-70. PubMed ID: 1968740
    [Abstract] [Full Text] [Related]

  • 23. Effect of antihypertensive agents on lipid metabolism.
    Cutler R.
    Am J Cardiol; 1983 Feb 24; 51(4):628-31. PubMed ID: 6131603
    [Abstract] [Full Text] [Related]

  • 24. Lipoprotein alterations in hemodialysis: differences between diabetic and nondiabetic patients.
    González AI, Schreier L, Elbert A, Berg G, Beresan H, López G, Wikinski R.
    Metabolism; 2003 Jan 24; 52(1):116-21. PubMed ID: 12524671
    [Abstract] [Full Text] [Related]

  • 25. Antihypertensive drugs and lipid profiles.
    Ames RP.
    Am J Hypertens; 1988 Oct 24; 1(4 Pt 1):421-7. PubMed ID: 2905605
    [Abstract] [Full Text] [Related]

  • 26. Alpha 1-blockade for the treatment of hypertension: a megastudy of terazosin in 2214 clinical practice settings.
    Itskovitz HD.
    Clin Ther; 1994 Oct 24; 16(3):490-504. PubMed ID: 7923316
    [Abstract] [Full Text] [Related]

  • 27. The effects of antihypertensive drugs on serum lipids and lipoproteins. II. Non-diuretic drugs.
    Ames RP.
    Drugs; 1986 Oct 24; 32(4):335-57. PubMed ID: 2877846
    [Abstract] [Full Text] [Related]

  • 28. The effects of the beta-adrenergic-blocking agents, timolol and carteolol, on plasma lipids and lipoproteins in Japanese glaucoma patients.
    Yamamoto T, Kitazawa Y, Noma A, Maeda S, Kato A, Ando Y, Ido T, Inazumi K, Hayakawa T, Goto Y, Ichien M.
    J Glaucoma; 1996 Aug 24; 5(4):252-7. PubMed ID: 8795770
    [Abstract] [Full Text] [Related]

  • 29. [Lipids, lipoproteins and apolipoproteins in normal newborns].
    Casanueva V, Cid X, Chiang MT, Molina M, Ferrada MC, Pérez R, Casanueva P.
    Rev Med Chil; 1998 Sep 24; 126(9):1073-8. PubMed ID: 9922510
    [Abstract] [Full Text] [Related]

  • 30. Use of antihypertensive agents in patients with glucose intolerance.
    McKenney JM, Goodman RP, Wright JT.
    Clin Pharm; 1985 Sep 24; 4(6):649-56. PubMed ID: 2866862
    [Abstract] [Full Text] [Related]

  • 31. [Effect on lipids, lipoproteins and apoproteins of labetalol prescribed in doses of 400 mg/day in hypertensive patients. Double-blind versus placebo study].
    Rouffy J, Bakir R, Chanu B, Djian F, Goy-Loeper J, Henry Amar M, Renon D, Pappo M.
    Pathol Biol (Paris); 1986 Apr 24; 34(4):253-8. PubMed ID: 3529000
    [Abstract] [Full Text] [Related]

  • 32. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR.
    Dan Med Bull; 2002 Feb 24; 49(1):43-60. PubMed ID: 11894723
    [Abstract] [Full Text] [Related]

  • 33. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    Teichmann A.
    Int J Fertil Menopausal Stud; 1995 Feb 24; 40 Suppl 2():98-104. PubMed ID: 8574257
    [Abstract] [Full Text] [Related]

  • 34. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
    Oida K, Nakai T, Tamai T, Kutsumi Y, Kobayashi T, Hayashi T, Yamada S, Takeda R.
    Artery; 1982 Feb 24; 10(4):266-85. PubMed ID: 7181672
    [Abstract] [Full Text] [Related]

  • 35. The effect of cyclosporine and methylprednisolone on plasma lipoprotein levels in rats.
    Espino A, Lopez-Miranda J, Blanco-Cerrada J, Zambrana JL, Aumente MA, Paniagua JA, Blanco-Molina A, Jimenez-Pereperez JA, Rodriguez M, Pérez-Jiméz F.
    J Lab Clin Med; 1995 Feb 24; 125(2):222-7. PubMed ID: 7844470
    [Abstract] [Full Text] [Related]

  • 36. Plasma lipid and lipoprotein changes in hypertensive patients treated with propranolol and prazosin.
    Gemma G, Montanari G, Suppa G, Paralovo A, Franceschini G, Mantero O, Sirtori CR.
    J Cardiovasc Pharmacol; 1982 Feb 24; 4 Suppl 2():S233-7. PubMed ID: 6177963
    [Abstract] [Full Text] [Related]

  • 37. Antihypertensive drugs and blood lipids.
    Elliott HL.
    J Hum Hypertens; 1990 Oct 24; 4 Suppl 3():17-9. PubMed ID: 2262938
    [Abstract] [Full Text] [Related]

  • 38. Understanding and treating dyslipidemia associated with noninsulin-dependent diabetes mellitus and hypertension.
    McKenney JM.
    Pharmacotherapy; 1993 Oct 24; 13(4):340-52. PubMed ID: 8361860
    [Abstract] [Full Text] [Related]

  • 39. Lipid metabolism: implications of alpha 1-blockade.
    Rosenthal J.
    J Clin Pharmacol; 1993 Sep 24; 33(9):883-7. PubMed ID: 7901243
    [Abstract] [Full Text] [Related]

  • 40. [Interference with lipid metabolism by various antihypertensive agents: facts and hypotheses].
    Rouffy J.
    Arch Mal Coeur Vaiss; 1987 Apr 24; 80 Spec No():43-6. PubMed ID: 2887148
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.